25 XP   0   0   10

Zhejiang Jingxin Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Zhejiang Jingxin Pharmaceutical Co Ltd together

PenkeI guess you are interested in Zhejiang Jingxin Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Zhejiang Jingxin Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Zhejiang Jingxin Pharmaceutical Co Ltd

I send you an email if I find something interesting about Zhejiang Jingxin Pharmaceutical Co Ltd.

Quick analysis of Zhejiang Jingxin Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Zhejiang Jingxin Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.08
When do you have the money?
1 year
How often do you get paid?
97.5%

What is your share worth?

Current worth
¥6.43
Expected worth in 1 year
¥6.86
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
¥1.03
Return On Investment
9.0%

For what price can you sell your share?

Current Price per Share
¥11.41
Expected price per share
¥8.0254118644068 - ¥11.90
How sure are you?
50%

1. Valuation of Zhejiang Jingxin Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥11.41

Intrinsic Value Per Share

¥5.16 - ¥22.95

Total Value Per Share

¥11.59 - ¥29.39

2. Growth of Zhejiang Jingxin Pharmaceutical Co Ltd (5 min.)




Is Zhejiang Jingxin Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$764.5m$686.1m$54.8m7.4%

How much money is Zhejiang Jingxin Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$21.3m$22.8m-$1.4m-7.0%
Net Profit Margin15.5%17.5%--

How much money comes from the company's main activities?

3. Financial Health of Zhejiang Jingxin Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Zhejiang Jingxin Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Zhejiang Jingxin Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Zhejiang Jingxin Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Zhejiang Jingxin Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Zhejiang Jingxin Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Zhejiang Jingxin Pharmaceutical Co Ltd is ¥11.41. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Zhejiang Jingxin Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Zhejiang Jingxin Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥6.43. Based on the TTM, the Book Value Change Per Share is ¥0.11 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.17 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.15 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Zhejiang Jingxin Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.020.2%0.030.2%0.030.2%0.020.2%0.020.1%
Usd Book Value Change Per Share0.020.2%0.010.1%0.020.2%0.020.1%0.020.2%
Usd Dividend Per Share0.000.0%0.020.2%0.040.4%0.020.2%0.010.1%
Usd Total Gains Per Share0.020.2%0.040.3%0.060.6%0.040.3%0.030.3%
Usd Price Per Share1.76-1.77-1.41-1.49-1.90-
Price to Earnings Ratio18.72-17.47-13.91-18.30-61.30-
Price-to-Total Gains Ratio71.17-58.71-22.39-717.34-452.80-
Price to Book Ratio1.98-2.05-1.79-2.17-4.95-
Price-to-Total Gains Ratio71.17-58.71-22.39-717.34-452.80-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.57458
Number of shares635
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.02
Usd Book Value Change Per Share0.010.02
Usd Total Gains Per Share0.040.04
Gains per Quarter (635 shares)22.5022.56
Gains per Year (635 shares)90.0190.22
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1533780504080
21057517010080170
3158112260151120260
4210150350201160350
5263187440251200440
6315225530301240530
7368262620351280620
8420300710402320710
9473337800452360800
10525375890502400890

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%76.00.03.096.2%
Book Value Change Per Share3.01.00.075.0%10.02.00.083.3%14.06.00.070.0%32.08.00.080.0%66.013.00.083.5%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%39.00.01.097.5%70.00.09.088.6%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%18.02.00.090.0%36.04.00.090.0%75.04.00.094.9%

Fundamentals of Zhejiang Jingxin Pharmaceutical Co Ltd

About Zhejiang Jingxin Pharmaceutical Co Ltd

Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products and medical devices in China. The company offers antihypertensive, antibiotics, quinolones, gastrointestinal promotion, antidiabetic, antiepileptic, antihistamine, H+ pump depressant, antihyper cholesterolemia, histamine H2 receptor blockader, antihyper cholesterolemirs, antidepressant, Cephalosporin, and biopharma products; and API products, including ciprofloxacin, ciprofloxacin hydrochloride, ciprofloxacin lactate, levofloxacin hemihydrate, levofloxacin hydrochloride, levofloxacin lactate, enrofloxacin, enrofloxacin hydrochloride, simvastatin, rosuvastatin calcium, pitavastatin calcium, sitagliptin, clopidogrel bisulfate, ticagrelor, rivaroxaban, apixaban, sisapele, esomeprazole, levetiracetam, bovaracetam, sertraline hydrochloride, pramipexole hydrochloride, rivastigmine bitartrate, memantine hydrochloride, and paliperidone. It also provides intermediates; and medical display products, such as diagnostic medical displays, surgical medical displays, clinical medical displays, medical large screens, medical integrated machines, and ultrasonic medical displays. The company was formerly known as Zhejiang Jingxin Pharmaceutical Factory and changed its name to Zhejiang Jingxin Pharmaceutical Co., Ltd. in 2000. Zhejiang Jingxin Pharmaceutical Co., Ltd. was founded in 1990 and is headquartered in Xinchang, China.

Fundamental data was last updated by Penke on 2024-04-14 12:19:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Zhejiang Jingxin Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Zhejiang Jingxin Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Zhejiang Jingxin Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 13.6% means that ¥0.14 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Zhejiang Jingxin Pharmaceutical Co Ltd:

  • The MRQ is 13.6%. The company is making a huge profit. +2
  • The TTM is 15.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ13.6%TTM15.5%-1.9%
TTM15.5%YOY17.5%-2.0%
TTM15.5%5Y17.1%-1.6%
5Y17.1%10Y14.3%+2.8%
1.1.2. Return on Assets

Shows how efficient Zhejiang Jingxin Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Zhejiang Jingxin Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.8% Return on Assets means that Zhejiang Jingxin Pharmaceutical Co Ltd generated ¥0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Zhejiang Jingxin Pharmaceutical Co Ltd:

  • The MRQ is 1.8%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.8%TTM2.0%-0.2%
TTM2.0%YOY2.4%-0.4%
TTM2.0%5Y2.5%-0.5%
5Y2.5%10Y2.1%+0.4%
1.1.3. Return on Equity

Shows how efficient Zhejiang Jingxin Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Zhejiang Jingxin Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.7% Return on Equity means Zhejiang Jingxin Pharmaceutical Co Ltd generated ¥0.03 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Zhejiang Jingxin Pharmaceutical Co Ltd:

  • The MRQ is 2.7%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.9%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.7%TTM2.9%-0.2%
TTM2.9%YOY3.3%-0.4%
TTM2.9%5Y3.5%-0.6%
5Y3.5%10Y3.0%+0.6%

1.2. Operating Efficiency of Zhejiang Jingxin Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Zhejiang Jingxin Pharmaceutical Co Ltd is operating .

  • Measures how much profit Zhejiang Jingxin Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Zhejiang Jingxin Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Zhejiang Jingxin Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM11.7%-11.7%
TTM11.7%YOY19.4%-7.8%
TTM11.7%5Y16.5%-4.8%
5Y16.5%10Y8.7%+7.8%
1.2.2. Operating Ratio

Measures how efficient Zhejiang Jingxin Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.36 means that the operating costs are ¥1.36 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Zhejiang Jingxin Pharmaceutical Co Ltd:

  • The MRQ is 1.362. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.334. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.362TTM1.334+0.028
TTM1.334YOY1.293+0.042
TTM1.3345Y1.261+0.074
5Y1.26110Y0.887+0.374

1.3. Liquidity of Zhejiang Jingxin Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Zhejiang Jingxin Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.62 means the company has ¥1.62 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Zhejiang Jingxin Pharmaceutical Co Ltd:

  • The MRQ is 1.616. The company is able to pay all its short-term debts. +1
  • The TTM is 1.594. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.616TTM1.594+0.023
TTM1.594YOY1.958-0.365
TTM1.5945Y1.947-0.353
5Y1.94710Y1.095+0.852
1.3.2. Quick Ratio

Measures if Zhejiang Jingxin Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Zhejiang Jingxin Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.35 means the company can pay off ¥0.35 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Zhejiang Jingxin Pharmaceutical Co Ltd:

  • The MRQ is 0.348. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.397. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.348TTM0.397-0.049
TTM0.397YOY0.507-0.110
TTM0.3975Y0.810-0.413
5Y0.81010Y0.712+0.098

1.4. Solvency of Zhejiang Jingxin Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Zhejiang Jingxin Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Zhejiang Jingxin Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.31 means that Zhejiang Jingxin Pharmaceutical Co Ltd assets are financed with 30.6% credit (debt) and the remaining percentage (100% - 30.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Zhejiang Jingxin Pharmaceutical Co Ltd:

  • The MRQ is 0.306. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.301. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.306TTM0.301+0.006
TTM0.301YOY0.280+0.021
TTM0.3015Y0.300+0.001
5Y0.30010Y0.280+0.021
1.4.2. Debt to Equity Ratio

Measures if Zhejiang Jingxin Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Zhejiang Jingxin Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 44.4% means that company has ¥0.44 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Zhejiang Jingxin Pharmaceutical Co Ltd:

  • The MRQ is 0.444. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.432. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.444TTM0.432+0.011
TTM0.432YOY0.392+0.040
TTM0.4325Y0.434-0.001
5Y0.43410Y0.396+0.038

2. Market Valuation of Zhejiang Jingxin Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Zhejiang Jingxin Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Zhejiang Jingxin Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 18.72 means the investor is paying ¥18.72 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Zhejiang Jingxin Pharmaceutical Co Ltd:

  • The EOD is 16.791. Based on the earnings, the company is fair priced.
  • The MRQ is 18.719. Based on the earnings, the company is fair priced.
  • The TTM is 17.469. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD16.791MRQ18.719-1.928
MRQ18.719TTM17.469+1.250
TTM17.469YOY13.909+3.560
TTM17.4695Y18.300-0.831
5Y18.30010Y61.303-43.003
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Zhejiang Jingxin Pharmaceutical Co Ltd:

  • The EOD is 11.380. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 12.686. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is -102.169. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD11.380MRQ12.686-1.307
MRQ12.686TTM-102.169+114.856
TTM-102.169YOY12.382-114.552
TTM-102.1695Y25.393-127.562
5Y25.39310Y47.508-22.116
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Zhejiang Jingxin Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Zhejiang Jingxin Pharmaceutical Co Ltd:

  • The EOD is 1.773. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.977. Based on the equity, the company is underpriced. +1
  • The TTM is 2.055. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.773MRQ1.977-0.204
MRQ1.977TTM2.055-0.078
TTM2.055YOY1.790+0.265
TTM2.0555Y2.171-0.116
5Y2.17110Y4.951-2.780
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Zhejiang Jingxin Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1790.107+67%0.166+8%0.114+56%0.137+30%
Book Value Per Share--6.4346.237+3%5.705+13%5.086+27%3.960+62%
Current Ratio--1.6161.594+1%1.958-17%1.947-17%1.095+48%
Debt To Asset Ratio--0.3060.301+2%0.280+9%0.300+2%0.280+10%
Debt To Equity Ratio--0.4440.432+3%0.392+13%0.434+2%0.396+12%
Dividend Per Share--0.0000.150-100%0.297-100%0.143-100%0.093-100%
Eps--0.1700.184-7%0.186-9%0.176-4%0.121+41%
Free Cash Flow Per Share--0.2510.079+216%0.101+147%0.056+351%0.080+215%
Free Cash Flow To Equity Per Share--0.251-0.004+102%0.047+436%-0.004+102%0.149+68%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--22.954--------
Intrinsic Value_10Y_min--5.156--------
Intrinsic Value_1Y_max--0.606--------
Intrinsic Value_1Y_min--0.277--------
Intrinsic Value_3Y_max--3.112--------
Intrinsic Value_3Y_min--1.045--------
Intrinsic Value_5Y_max--7.175--------
Intrinsic Value_5Y_min--2.040--------
Market Cap9824340798.720-11%10952290660.80011027630710.550-1%8915301073.975+23%9398460866.952+17%11898941759.905-8%
Net Profit Margin--0.1360.155-12%0.175-22%0.171-20%0.143-5%
Operating Margin---0.117-100%0.194-100%0.165-100%0.087-100%
Operating Ratio--1.3621.334+2%1.293+5%1.261+8%0.887+54%
Pb Ratio1.773-11%1.9772.055-4%1.790+10%2.171-9%4.951-60%
Pe Ratio16.791-11%18.71917.469+7%13.909+35%18.300+2%61.303-69%
Price Per Share11.410-11%12.72012.808-1%10.225+24%10.828+17%13.776-8%
Price To Free Cash Flow Ratio11.380-11%12.686-102.169+905%12.382+2%25.393-50%47.508-73%
Price To Total Gains Ratio63.839-11%71.16858.707+21%22.391+218%717.338-90%452.796-84%
Quick Ratio--0.3480.397-12%0.507-31%0.810-57%0.712-51%
Return On Assets--0.0180.020-9%0.024-23%0.025-26%0.021-13%
Return On Equity--0.0270.029-8%0.033-21%0.035-25%0.030-11%
Total Gains Per Share--0.1790.257-30%0.463-61%0.257-31%0.230-22%
Usd Book Value--764541432.093741081151.967+3%686193971.194+11%609909249.943+25%473340476.757+62%
Usd Book Value Change Per Share--0.0250.015+67%0.023+8%0.016+56%0.019+30%
Usd Book Value Per Share--0.8880.861+3%0.787+13%0.702+27%0.546+62%
Usd Dividend Per Share--0.0000.021-100%0.041-100%0.020-100%0.013-100%
Usd Eps--0.0230.025-7%0.026-9%0.024-4%0.017+41%
Usd Free Cash Flow--29785001.7229429658.244+216%11737056.004+154%6563935.979+354%9435786.285+216%
Usd Free Cash Flow Per Share--0.0350.011+216%0.014+147%0.008+351%0.011+215%
Usd Free Cash Flow To Equity Per Share--0.035-0.001+102%0.006+436%-0.001+102%0.021+68%
Usd Market Cap1355759030.223-11%1511416111.1901521813038.056-1%1230311548.209+23%1296987599.639+17%1642053962.867-8%
Usd Price Per Share1.575-11%1.7551.767-1%1.411+24%1.494+17%1.901-8%
Usd Profit--20185880.77021351982.164-5%22847756.927-12%21173473.667-5%14448958.493+40%
Usd Revenue--148115095.140137959815.086+7%130404696.849+14%124333941.292+19%95598954.032+55%
Usd Total Gains Per Share--0.0250.035-30%0.064-61%0.036-31%0.032-22%
 EOD+4 -4MRQTTM+15 -20YOY+15 -205Y+16 -1910Y+19 -16

3.2. Fundamental Score

Let's check the fundamental score of Zhejiang Jingxin Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1516.791
Price to Book Ratio (EOD)Between0-11.773
Net Profit Margin (MRQ)Greater than00.136
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.348
Current Ratio (MRQ)Greater than11.616
Debt to Asset Ratio (MRQ)Less than10.306
Debt to Equity Ratio (MRQ)Less than10.444
Return on Equity (MRQ)Greater than0.150.027
Return on Assets (MRQ)Greater than0.050.018
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Zhejiang Jingxin Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5064.288
Ma 20Greater thanMa 5010.568
Ma 50Greater thanMa 10010.662
Ma 100Greater thanMa 20011.325
OpenGreater thanClose11.440
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets7,986,557
Total Liabilities2,446,402
Total Stockholder Equity5,512,374
 As reported
Total Liabilities 2,446,402
Total Stockholder Equity+ 5,512,374
Total Assets = 7,986,557

Assets

Total Assets7,986,557
Total Current Assets3,353,735
Long-term Assets4,632,822
Total Current Assets
Cash And Cash Equivalents 1,460,813
Short-term Investments 150,956
Net Receivables 571,456
Inventory 652,687
Other Current Assets 435,227
Total Current Assets  (as reported)3,353,735
Total Current Assets  (calculated)3,271,139
+/- 82,596
Long-term Assets
Property Plant Equipment 2,300,196
Goodwill 348,485
Intangible Assets 401,264
Long-term Assets Other 521,235
Long-term Assets  (as reported)4,632,822
Long-term Assets  (calculated)3,571,180
+/- 1,061,643

Liabilities & Shareholders' Equity

Total Current Liabilities2,074,759
Long-term Liabilities371,643
Total Stockholder Equity5,512,374
Total Current Liabilities
Short Long Term Debt 279,091
Accounts payable 941,160
Other Current Liabilities 4,263
Total Current Liabilities  (as reported)2,074,759
Total Current Liabilities  (calculated)1,224,514
+/- 850,245
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt31,228
Long-term Liabilities Other 3,203
Long-term Liabilities  (as reported)371,643
Long-term Liabilities  (calculated)34,430
+/- 337,213
Total Stockholder Equity
Retained Earnings 2,540,094
Total Stockholder Equity (as reported)5,512,374
Total Stockholder Equity (calculated)2,540,094
+/- 2,972,281
Other
Capital Stock861,029
Common Stock Shares Outstanding 861,029
Net Invested Capital 5,791,466
Net Working Capital 1,278,976
Property Plant and Equipment Gross 2,300,196



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302003-12-312002-12-312001-12-31
> Total Assets 
152,501
182,372
258,805
319,313
449,126
465,135
499,668
502,929
505,191
568,915
669,552
710,314
760,627
772,847
915,421
933,394
984,588
1,015,786
1,046,703
1,101,643
1,041,968
953,084
995,971
1,044,216
1,010,983
917,221
853,609
910,435
941,012
949,146
951,730
984,279
937,819
1,192,559
1,198,971
1,254,844
1,266,040
1,300,978
1,368,261
1,443,212
1,289,948
1,324,631
1,383,485
1,836,711
1,895,073
2,064,659
2,143,937
2,052,404
2,126,506
2,939,892
3,084,696
3,093,026
3,110,292
3,290,626
3,367,759
3,405,865
4,473,978
4,903,994
4,973,718
4,640,723
4,989,705
4,991,769
5,246,389
5,280,199
5,446,582
5,625,088
5,841,770
5,441,437
5,463,793
5,666,247
5,606,221
5,508,320
6,142,611
6,415,365
6,573,666
6,705,504
7,013,432
7,362,556
7,554,115
7,560,807
7,620,113
7,986,557
7,986,5577,620,1137,560,8077,554,1157,362,5567,013,4326,705,5046,573,6666,415,3656,142,6115,508,3205,606,2215,666,2475,463,7935,441,4375,841,7705,625,0885,446,5825,280,1995,246,3894,991,7694,989,7054,640,7234,973,7184,903,9944,473,9783,405,8653,367,7593,290,6263,110,2923,093,0263,084,6962,939,8922,126,5062,052,4042,143,9372,064,6591,895,0731,836,7111,383,4851,324,6311,289,9481,443,2121,368,2611,300,9781,266,0401,254,8441,198,9711,192,559937,819984,279951,730949,146941,012910,435853,609917,2211,010,9831,044,216995,971953,0841,041,9681,101,6431,046,7031,015,786984,588933,394915,421772,847760,627710,314669,552568,915505,191502,929499,668465,135449,126319,313258,805182,372152,501
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,168,327
3,035,533
3,272,392
3,297,417
3,398,779
3,485,166
3,728,251
3,281,092
3,192,859
3,125,014
2,803,850
2,663,118
3,152,287
3,229,523
3,144,265
3,130,745
3,271,012
3,281,166
3,237,902
3,019,394
2,733,582
3,353,735
3,353,7352,733,5823,019,3943,237,9023,281,1663,271,0123,130,7453,144,2653,229,5233,152,2872,663,1182,803,8503,125,0143,192,8593,281,0923,728,2513,485,1663,398,7793,297,4173,272,3923,035,5333,168,327000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
420,696
410,872
591,041
392,641
444,736
493,219
556,328
561,228
864,146
915,349
1,035,057
824,174
1,408,601
1,554,792
1,655,392
1,492,178
1,543,092
1,548,475
1,501,158
1,484,616
1,243,076
1,460,813
1,460,8131,243,0761,484,6161,501,1581,548,4751,543,0921,492,1781,655,3921,554,7921,408,601824,1741,035,057915,349864,146561,228556,328493,219444,736392,641591,041410,872420,696000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,445,000
0
1,920,000
1,975,000
1,948,403
2,118,216
1,685,729
1,266,455
1,178,834
630,736
616,123
471,041
422,396
130,133
150,628
295,585
366,885
321,271
226,513
181,613
150,956
150,956181,613226,513321,271366,885295,585150,628130,133422,396471,041616,123630,7361,178,8341,266,4551,685,7292,118,2161,948,4031,975,0001,920,00001,445,0000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
35,579
32,038
44,416
45,002
50,447
58,243
59,698
55,406
34,494
40,882
49,184
59,038
56,791
58,437
79,131
88,887
109,584
102,436
102,417
114,430
97,319
102,201
120,064
105,540
113,300
99,542
89,496
105,100
109,579
100,247
116,983
121,970
106,515
91,585
117,512
148,260
132,302
132,529
133,850
165,119
180,347
181,907
184,912
217,967
217,121
226,969
251,454
274,755
273,514
358,722
453,592
492,157
401,640
404,836
399,733
410,055
454,913
691,532
717,218
664,303
706,154
557,682
488,494
461,937
485,412
517,136
506,395
484,720
465,496
433,293
480,804
581,564
566,910
584,645
635,431
677,225
598,383
474,434
475,043
568,326
573,601
571,456
571,456573,601568,326475,043474,434598,383677,225635,431584,645566,910581,564480,804433,293465,496484,720506,395517,136485,412461,937488,494557,682706,154664,303717,218691,532454,913410,055399,733404,836401,640492,157453,592358,722273,514274,755251,454226,969217,121217,967184,912181,907180,347165,119133,850132,529132,302148,260117,51291,585106,515121,970116,983100,247109,579105,10089,49699,542113,300105,540120,064102,20197,319114,430102,417102,436109,58488,88779,13158,43756,79159,03849,18440,88234,49455,40659,69858,24350,44745,00244,41632,03835,579
       Other Current Assets 
14,315
23,189
40,473
28,786
42,310
58,432
43,637
33,638
51,594
67,123
54,512
54,372
45,777
23,997
32,460
36,777
44,313
51,238
46,431
40,363
39,138
17,533
20,711
24,029
27,957
20,594
37,090
69,985
80,157
132,054
129,477
131,081
133,630
23,531
42,262
12,746
18,222
14,426
32,163
38,425
29,067
11,507
20,553
22,339
10,454
5,468
356,700
10,048
328,301
13,411
410,735
16,284
441,612
22,468
621,217
40,890
1,657,457
29,866
1,605,743
25,053
1,692,226
259,409
1,653,420
7,338
4,119
19,378
144,795
22,343
115,467
24,347
101,943
12,276
133,600
17,734
41,396
16,284
33,570
22,078
21,549
16,307
57,777
435,227
435,22757,77716,30721,54922,07833,57016,28441,39617,734133,60012,276101,94324,347115,46722,343144,79519,3784,1197,3381,653,420259,4091,692,22625,0531,605,74329,8661,657,45740,890621,21722,468441,61216,284410,73513,411328,30110,048356,7005,46810,45422,33920,55311,50729,06738,42532,16314,42618,22212,74642,26223,531133,630131,081129,477132,05480,15769,98537,09020,59427,95724,02920,71117,53339,13840,36346,43151,23844,31336,77732,46023,99745,77754,37254,51267,12351,59433,63843,63758,43242,31028,78640,47323,18914,315
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,973,997
1,982,782
2,047,803
2,139,922
2,113,519
2,160,345
2,270,935
2,541,233
2,802,371
2,845,201
2,990,323
3,185,842
3,429,400
3,574,759
3,742,420
4,081,390
4,316,213
4,541,413
4,886,531
4,632,822
4,632,8224,886,5314,541,4134,316,2134,081,3903,742,4203,574,7593,429,4003,185,8422,990,3232,845,2012,802,3712,541,2332,270,9352,160,3452,113,5192,139,9222,047,8031,982,7821,973,99700000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
28,328
48,529
91,341
114,233
124,701
136,995
151,309
236,935
190,376
322,587
290,871
386,404
332,959
449,245
386,969
449,789
345,082
490,846
394,599
498,006
393,749
501,172
402,098
489,379
384,157
436,483
338,184
424,056
336,622
428,365
338,014
437,190
343,768
552,148
465,981
554,119
406,934
496,975
425,429
517,123
460,528
592,576
513,035
555,802
589,132
614,131
626,360
635,690
642,345
664,431
666,600
677,274
679,108
705,400
732,806
734,975
737,735
731,936
744,711
757,393
771,240
817,129
843,772
862,844
912,439
962,422
974,811
1,011,989
1,036,957
1,078,812
1,129,661
1,186,675
1,234,530
1,262,897
1,336,166
1,416,100
1,493,580
1,632,141
1,744,759
1,877,425
2,094,601
2,300,196
2,300,1962,094,6011,877,4251,744,7591,632,1411,493,5801,416,1001,336,1661,262,8971,234,5301,186,6751,129,6611,078,8121,036,9571,011,989974,811962,422912,439862,844843,772817,129771,240757,393744,711731,936737,735734,975732,806705,400679,108677,274666,600664,431642,345635,690626,360614,131589,132555,802513,035592,576460,528517,123425,429496,975406,934554,119465,981552,148343,768437,190338,014428,365336,622424,056338,184436,483384,157489,379402,098501,172393,749498,006394,599490,846345,082449,789386,969449,245332,959386,404290,871322,587190,376236,935151,309136,995124,701114,23391,34148,52928,328
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
423,403
423,403
423,403
423,403
414,403
414,403
414,403
414,403
257,886
257,886
257,886
257,886
257,886
259,296
259,296
259,296
257,886
257,886
257,886
257,886
257,886
257,886
257,886
257,886
257,886
361,176
361,176
361,176
348,485
348,485
348,485
348,485
348,485
348,485348,485348,485348,485348,485361,176361,176361,176257,886257,886257,886257,886257,886257,886257,886257,886257,886259,296259,296259,296257,886257,886257,886257,886257,886414,403414,403414,403414,403423,403423,403423,403423,4030000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
496,315
530,327
513,715
505,692
490,082
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000490,082505,692513,715530,327496,315000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
7,912
19,344
21,755
39,869
59,934
68,942
68,576
68,210
67,885
72,007
71,642
71,276
70,911
75,670
79,399
4,506
69,161
0
104,157
2,800
105,879
25
101,963
22
100,861
0
91,402
3,686
91,003
0
89,955
0
93,296
0
87,951
37,746
121,512
35,809
118,600
33,863
115,677
31,918
112,755
111,294
109,833
108,372
106,911
105,449
103,988
613,984
608,862
604,183
599,059
588,792
583,875
580,353
576,255
415,810
411,447
406,687
144,809
141,235
148,632
56,920
169,835
166,572
161,500
156,974
154,155
150,768
148,391
145,935
143,448
137,732
393,126
406,350
404,275
418,588
416,279
411,113
406,976
401,264
401,264406,976411,113416,279418,588404,275406,350393,126137,732143,448145,935148,391150,768154,155156,974161,500166,572169,83556,920148,632141,235144,809406,687411,447415,810576,255580,353583,875588,792599,059604,183608,862613,984103,988105,449106,911108,372109,833111,294112,75531,918115,67733,863118,60035,809121,51237,74687,951093,296089,955091,0033,68691,4020100,86122101,96325105,8792,800104,157069,1614,50679,39975,67070,91171,27671,64272,00767,88568,21068,57668,94259,93439,86921,75519,3447,912
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,200
300,535
16,740
77,210
78,233
78,111
1,206,813
246,804
467,277
464,562
572,296
732,016
630,873
684,411
663,226
861,189
996,509
1,095,246
1,220,755
521,235
521,2351,220,7551,095,246996,509861,189663,226684,411630,873732,016572,296464,562467,277246,8041,206,81378,11178,23377,21016,740300,53510,20000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
111,828
119,352
170,364
216,184
176,266
181,109
212,138
216,340
215,898
279,270
376,340
416,089
463,478
478,232
616,704
633,411
684,032
716,176
746,945
801,253
741,430
649,891
692,537
739,327
704,646
610,055
544,472
596,385
623,795
629,021
625,044
647,717
616,866
426,392
425,441
471,436
498,669
528,398
581,820
655,609
481,211
506,653
540,819
485,749
510,584
666,121
704,389
558,821
626,679
679,390
763,705
744,007
697,631
864,229
866,363
873,564
770,326
938,431
970,081
993,846
1,288,215
1,418,374
1,650,999
1,691,980
1,713,613
1,914,376
2,105,001
1,935,615
1,813,828
1,733,578
1,520,220
1,512,070
1,492,681
1,577,711
1,661,055
1,891,850
2,021,985
2,190,586
2,230,250
2,330,476
2,233,851
2,446,402
2,446,4022,233,8512,330,4762,230,2502,190,5862,021,9851,891,8501,661,0551,577,7111,492,6811,512,0701,520,2201,733,5781,813,8281,935,6152,105,0011,914,3761,713,6131,691,9801,650,9991,418,3741,288,215993,846970,081938,431770,326873,564866,363864,229697,631744,007763,705679,390626,679558,821704,389666,121510,584485,749540,819506,653481,211655,609581,820528,398498,669471,436425,441426,392616,866647,717625,044629,021623,795596,385544,472610,055704,646739,327692,537649,891741,430801,253746,945716,176684,032633,411616,704478,232463,478416,089376,340279,270215,898216,340212,138181,109176,266216,184170,364119,352111,828
   > Total Current Liabilities 
110,796
98,284
139,276
167,096
137,179
142,019
173,048
177,250
176,808
278,238
375,308
415,057
434,446
428,793
569,848
499,138
552,340
537,067
570,419
627,308
570,069
628,995
652,426
718,432
638,751
540,133
434,548
446,462
477,477
457,232
456,377
562,402
496,169
356,277
357,396
399,634
445,333
461,406
519,739
597,222
431,217
454,850
475,708
424,184
455,539
604,004
642,767
499,517
568,260
616,983
701,970
682,963
637,271
798,359
799,956
808,344
705,994
869,400
902,295
925,412
1,220,617
1,341,006
1,574,748
1,615,520
1,638,363
1,770,292
1,961,932
1,795,310
1,677,423
1,546,859
1,313,365
1,313,552
1,300,442
1,385,116
1,447,498
1,644,136
1,677,744
1,815,386
1,862,260
1,952,511
1,856,448
2,074,759
2,074,7591,856,4481,952,5111,862,2601,815,3861,677,7441,644,1361,447,4981,385,1161,300,4421,313,5521,313,3651,546,8591,677,4231,795,3101,961,9321,770,2921,638,3631,615,5201,574,7481,341,0061,220,617925,412902,295869,400705,994808,344799,956798,359637,271682,963701,970616,983568,260499,517642,767604,004455,539424,184475,708454,850431,217597,222519,739461,406445,333399,634357,396356,277496,169562,402456,377457,232477,477446,462434,548540,133638,751718,432652,426628,995570,069627,308570,419537,067552,340499,138569,848428,793434,446415,057375,308278,238176,808177,250173,048142,019137,179167,096139,27698,284110,796
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
255,889
360,794
310,801
358,500
500,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000500,000358,500310,801360,794255,88900000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
255,889
360,794
310,801
358,500
500,000
450,000
350,029
300,125
0
100,000
100,000
148,329
148,329
229,068
239,068
238,584
229,288
359,318
359,318
279,091
279,091359,318359,318229,288238,584239,068229,068148,329148,329100,000100,0000300,125350,029450,000500,000358,500310,801360,794255,88900000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
38,066
32,551
58,998
89,626
89,942
92,190
97,240
105,184
93,460
110,076
172,477
189,451
206,868
187,229
327,388
300,342
291,995
260,933
291,916
352,588
286,447
208,506
267,123
316,991
313,433
244,043
176,315
173,106
189,292
179,609
154,883
159,017
134,077
111,803
117,238
172,548
202,976
211,075
258,547
265,849
204,818
245,423
256,741
295,131
325,862
403,071
432,767
282,745
358,684
316,154
382,874
403,928
419,892
316,999
331,072
351,701
339,981
368,304
360,000
398,968
460,625
422,050
609,124
526,683
484,341
456,561
456,053
422,150
398,445
369,053
453,947
472,113
451,159
435,052
469,235
628,657
693,073
719,124
799,285
883,485
779,953
941,160
941,160779,953883,485799,285719,124693,073628,657469,235435,052451,159472,113453,947369,053398,445422,150456,053456,561484,341526,683609,124422,050460,625398,968360,000368,304339,981351,701331,072316,999419,892403,928382,874316,154358,684282,745432,767403,071325,862295,131256,741245,423204,818265,849258,547211,075202,976172,548117,238111,803134,077159,017154,883179,609189,292173,106176,315244,043313,433316,991267,123208,506286,447352,588291,916260,933291,995300,342327,388187,229206,868189,451172,477110,07693,460105,18497,24092,19089,94289,62658,99832,55138,066
       Other Current Liabilities 
37,980
23,983
20,278
22,470
22,237
22,829
21,808
18,066
29,348
36,103
21,772
17,106
9,078
30,064
25,960
17,296
33,845
46,134
58,503
49,220
40,622
42,489
21,303
47,441
48,018
48,790
64,933
70,056
75,185
43,031
47,902
37,808
23,015
28,882
32,566
43,494
61,765
47,065
48,961
68,050
80,654
84,980
102,310
114,177
125,469
161,777
192,227
202,189
195,247
248,991
218,535
189,035
216,378
281,359
268,884
256,643
316,012
501,096
542,295
526,443
579,178
641,906
652,679
200,255
804,551
813,045
901,757
226,598
837,537
696,238
726,390
614,476
625,963
603,986
690,759
643,125
625,246
9,275
698,668
570,083
591,582
4,263
4,263591,582570,083698,6689,275625,246643,125690,759603,986625,963614,476726,390696,238837,537226,598901,757813,045804,551200,255652,679641,906579,178526,443542,295501,096316,012256,643268,884281,359216,378189,035218,535248,991195,247202,189192,227161,777125,469114,177102,31084,98080,65468,05048,96147,06561,76543,49432,56628,88223,01537,80847,90243,03175,18570,05664,93348,79048,01847,44121,30342,48940,62249,22058,50346,13433,84517,29625,96030,0649,07817,10621,77236,10329,34818,06621,80822,82922,23722,47020,27823,98337,980
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
76,251
76,460
75,250
144,084
143,069
140,305
136,405
186,719
206,855
198,518
192,239
192,595
213,558
247,715
344,241
375,199
367,990
377,964
377,402
371,643
371,643377,402377,964367,990375,199344,241247,715213,558192,595192,239198,518206,855186,719136,405140,305143,069144,08475,25076,46076,25100000000000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-255,889
-360,794
-310,801
-358,500
-500,000
0
0
0
22,841
21,779
19,249
6,513
28,576
27,523
25,774
42,979
42,533
38,817
38,741
31,228
31,22838,74138,81742,53342,97925,77427,52328,5766,51319,24921,77922,841000-500,000-358,500-310,801-360,794-255,88900000000000000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
745
743
737
742
742
756
759
817
817
788
788
743
743
723
723
1,941
1,941
1,941
1,941
3,203
3,2031,9411,9411,9411,94172372374374378878881781775975674274273774374500000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,614
13,096
11,308
9,566
14,818
34,283
36,219
35,527
33,466
74,027
67,463
60,223
52,507
54,245
48,740
40,336
31,828
26,711
0
21,623
22,614
0
022,61421,623026,71131,82840,33648,74054,24552,50760,22367,46374,02733,46635,52736,21934,28314,8189,56611,30813,09614,614000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
40,673
63,020
88,441
101,645
271,387
279,526
283,030
280,589
282,293
282,644
286,212
292,724
295,649
293,136
297,237
298,535
299,168
298,179
298,226
298,927
299,152
299,290
299,336
300,955
302,432
303,042
304,932
310,065
312,976
315,938
322,370
332,243
320,953
766,167
773,530
783,409
767,370
772,580
786,441
787,603
808,737
817,978
842,665
1,350,962
1,384,490
1,398,538
1,439,548
1,493,583
1,499,827
2,216,882
2,277,411
2,304,856
2,366,962
2,381,008
2,454,624
2,487,104
3,657,155
3,920,618
3,961,291
3,606,808
3,689,492
3,561,772
3,583,363
3,576,051
3,720,841
3,696,080
3,722,181
3,489,979
3,635,737
3,917,603
4,067,612
3,977,481
4,630,980
4,817,411
4,890,801
4,789,238
4,967,428
5,146,123
5,297,452
5,204,304
5,361,097
5,512,374
5,512,3745,361,0975,204,3045,297,4525,146,1234,967,4284,789,2384,890,8014,817,4114,630,9803,977,4814,067,6123,917,6033,635,7373,489,9793,722,1813,696,0803,720,8413,576,0513,583,3633,561,7723,689,4923,606,8083,961,2913,920,6183,657,1552,487,1042,454,6242,381,0082,366,9622,304,8562,277,4112,216,8821,499,8271,493,5831,439,5481,398,5381,384,4901,350,962842,665817,978808,737787,603786,441772,580767,370783,409773,530766,167320,953332,243322,370315,938312,976310,065304,932303,042302,432300,955299,336299,290299,152298,927298,226298,179299,168298,535297,237293,136295,649292,724286,212282,644282,293280,589283,030279,526271,387101,64588,44163,02040,673
   Common Stock
30,000
50,100
50,100
50,100
67,700
67,700
67,700
67,700
67,700
67,700
67,700
101,550
101,550
101,550
101,550
101,550
101,550
101,550
101,550
101,550
101,550
101,550
101,550
101,550
101,550
101,550
101,550
101,550
101,550
101,550
101,550
101,550
101,550
126,331
126,331
126,331
126,331
126,331
126,331
252,663
252,663
252,663
252,663
286,451
286,451
286,451
286,451
286,451
286,451
319,588
319,588
639,176
639,176
639,176
639,176
637,998
736,125
736,125
736,125
724,872
724,872
724,872
724,872
724,872
724,872
724,872
724,872
724,872
724,872
705,508
705,508
837,751
905,319
905,319
905,319
905,319
861,029
861,029
0
861,029
861,029
0
0861,029861,0290861,029861,029905,319905,319905,319905,319837,751705,508705,508724,872724,872724,872724,872724,872724,872724,872724,872724,872724,872736,125736,125736,125637,998639,176639,176639,176639,176319,588319,588286,451286,451286,451286,451286,451286,451252,663252,663252,663252,663126,331126,331126,331126,331126,331126,331101,550101,550101,550101,550101,550101,550101,550101,550101,550101,550101,550101,550101,550101,550101,550101,550101,550101,550101,550101,550101,550101,55067,70067,70067,70067,70067,70067,70067,70050,10050,10050,10030,000
   Retained Earnings 
2,382
9,022
30,615
43,796
48,205
52,576
56,079
53,638
55,342
55,142
58,710
65,222
68,147
64,918
68,900
70,198
70,831
69,693
69,739
70,440
70,666
50,470
50,516
52,136
53,613
53,554
55,444
60,577
63,488
66,100
72,532
82,405
91,105
93,302
100,665
110,543
94,505
98,024
111,885
113,048
134,182
140,321
189,087
198,637
232,165
246,214
287,224
341,258
347,502
369,290
429,819
457,264
519,371
533,302
606,941
639,422
718,506
720,774
808,800
790,836
951,056
947,802
973,387
963,046
1,126,244
1,345,279
1,441,828
1,339,520
1,485,886
1,766,406
1,895,763
1,805,741
1,964,190
2,148,981
2,313,660
2,211,954
2,389,840
2,553,615
2,380,039
2,611,231
2,767,930
2,540,094
2,540,0942,767,9302,611,2312,380,0392,553,6152,389,8402,211,9542,313,6602,148,9811,964,1901,805,7411,895,7631,766,4061,485,8861,339,5201,441,8281,345,2791,126,244963,046973,387947,802951,056790,836808,800720,774718,506639,422606,941533,302519,371457,264429,819369,290347,502341,258287,224246,214232,165198,637189,087140,321134,182113,048111,88598,02494,505110,543100,66593,30291,10582,40572,53266,10063,48860,57755,44453,55453,61352,13650,51650,47070,66670,44069,73969,69370,83170,19868,90064,91868,14765,22258,71055,14255,34253,63856,07952,57648,20543,79630,6159,0222,382
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000-140,370-107,344-47,3180000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
104,698
76,001
74,306
77,335
63,884
4,989
5,237
5,172
5,025
6,370
6,505
6,396
6,406
8,046
8,257
8,399
8,704
11,310
0
11,875
11,970
0
011,97011,875011,3108,7048,3998,2578,0466,4066,3966,5056,3705,0255,1725,2374,98963,88477,33574,30676,001104,698000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue3,998,835
Cost of Revenue-1,976,488
Gross Profit2,022,3472,022,347
 
Operating Income (+$)
Gross Profit2,022,347
Operating Expense-3,362,392
Operating Income636,443-1,340,045
 
Operating Expense (+$)
Research Development400,935
Selling General Administrative849,445
Selling And Marketing Expenses0
Operating Expense3,362,3921,250,380
 
Net Interest Income (+$)
Interest Income60,269
Interest Expense-7,315
Other Finance Cost-2,561
Net Interest Income50,394
 
Pretax Income (+$)
Operating Income636,443
Net Interest Income50,394
Other Non-Operating Income Expenses0
Income Before Tax (EBT)708,041636,443
EBIT - interestExpense = -7,315
618,898
626,213
Interest Expense7,315
Earnings Before Interest and Taxes (EBIT)0715,356
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax708,041
Tax Provision-84,623
Net Income From Continuing Ops623,418623,418
Net Income618,898
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-50,394
 

Technical Analysis of Zhejiang Jingxin Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Zhejiang Jingxin Pharmaceutical Co Ltd. The general trend of Zhejiang Jingxin Pharmaceutical Co Ltd is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Zhejiang Jingxin Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Zhejiang Jingxin Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 11.46 < 11.57 < 11.90.

The bearish price targets are: 9.96 > 8.28 > 8.0254118644068.

Tweet this
Zhejiang Jingxin Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Zhejiang Jingxin Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Zhejiang Jingxin Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Zhejiang Jingxin Pharmaceutical Co Ltd. The current macd is 0.06762948.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Zhejiang Jingxin Pharmaceutical Co Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Zhejiang Jingxin Pharmaceutical Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Zhejiang Jingxin Pharmaceutical Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Zhejiang Jingxin Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartZhejiang Jingxin Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Zhejiang Jingxin Pharmaceutical Co Ltd. The current adx is 22.05.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Zhejiang Jingxin Pharmaceutical Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Zhejiang Jingxin Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Zhejiang Jingxin Pharmaceutical Co Ltd. The current sar is 10.18.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Zhejiang Jingxin Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Zhejiang Jingxin Pharmaceutical Co Ltd. The current rsi is 64.29. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Zhejiang Jingxin Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartZhejiang Jingxin Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Zhejiang Jingxin Pharmaceutical Co Ltd. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Zhejiang Jingxin Pharmaceutical Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Zhejiang Jingxin Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartZhejiang Jingxin Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Zhejiang Jingxin Pharmaceutical Co Ltd. The current cci is 183.41.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Zhejiang Jingxin Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartZhejiang Jingxin Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Zhejiang Jingxin Pharmaceutical Co Ltd. The current cmo is 43.98.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Zhejiang Jingxin Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartZhejiang Jingxin Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Zhejiang Jingxin Pharmaceutical Co Ltd. The current willr is -13.17365269.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Zhejiang Jingxin Pharmaceutical Co Ltd Daily Williams %R ChartZhejiang Jingxin Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Zhejiang Jingxin Pharmaceutical Co Ltd.

Zhejiang Jingxin Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Zhejiang Jingxin Pharmaceutical Co Ltd. The current atr is 0.35902334.

Zhejiang Jingxin Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartZhejiang Jingxin Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Zhejiang Jingxin Pharmaceutical Co Ltd. The current obv is 379,493,735.

Zhejiang Jingxin Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartZhejiang Jingxin Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Zhejiang Jingxin Pharmaceutical Co Ltd. The current mfi is 68.47.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Zhejiang Jingxin Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartZhejiang Jingxin Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Zhejiang Jingxin Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-04BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-31ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-26STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Zhejiang Jingxin Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Zhejiang Jingxin Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5064.288
Ma 20Greater thanMa 5010.568
Ma 50Greater thanMa 10010.662
Ma 100Greater thanMa 20011.325
OpenGreater thanClose11.440
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Zhejiang Jingxin Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Zhejiang Jingxin Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Zhejiang Jingxin Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Zhejiang Jingxin Pharmaceutical Co Ltd

I send you an email if I find something interesting about Zhejiang Jingxin Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Zhejiang Jingxin Pharmaceutical Co Ltd.

Receive notifications about Zhejiang Jingxin Pharmaceutical Co Ltd in your mailbox!